{"DataElement":{"publicId":"2003586","version":"6","preferredName":"Access Route of Administration Text Code","preferredDefinition":"A  text code or name to represent an access route for the administration of agents or substances.","longName":"ACCESS_RTE_TXT_CD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2012668","version":"3","preferredName":"Access Route","preferredDefinition":"An established means of access (for administration of agents, taking vital signs, etc.).","longName":"ACCESS_RTE","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2635254","version":"1","preferredName":"Access","preferredDefinition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","longName":"C25396","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Access","conceptCode":"C25396","definition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6F5266-4618-4643-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2452898","version":"1","preferredName":"Route","preferredDefinition":"A method of achieving something. (from Cambridge Advanced Learner's Dictionary - online)","longName":"C25169","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route","conceptCode":"C25169","definition":"A way of getting from one place to another; an established line of travel or access; the way a chemical or pollutant enters an organism after contact, particularly, the way of drug administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6BC1-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"ONEDATA","dateModified":"2006-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A56E8150-8ED5-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"REEVESD","dateModified":"2016-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180809","version":"6","preferredName":"Route of Administration Text Code","preferredDefinition":"An enumerated set of text codes and names to represent an access route for the administration of agents, evaluation of vital signs, etc.","longName":"ACCESS_RTE_NM_TXT_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Otic","valueDescription":"Auricular Route of Administration","ValueMeaning":{"publicId":"2576423","version":"1","preferredName":"Auricular Route of Administration","longName":"2576423","preferredDefinition":"Administration to or by way of the ear.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Auricular Route of Administration","conceptCode":"C38192","definition":"Administration of the drug to or by way of the ear. The drug action is mostly topical/local.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F794-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-04","modifiedBy":"ONEDATA","dateModified":"2005-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F49-4ACD-E044-0003BA3F9857","beginDate":"2005-10-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"ENDOTR","valueDescription":"Endotracheal Route of Administration","ValueMeaning":{"publicId":"2577075","version":"1","preferredName":"Endotracheal Route of Administration","longName":"2577075","preferredDefinition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endotracheal Route of Administration","conceptCode":"C38208","definition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA20-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F53-4ACD-E044-0003BA3F9857","beginDate":"2005-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Interstl","valueDescription":"Interstitial Route of Administration","ValueMeaning":{"publicId":"2577989","version":"1","preferredName":"Interstitial Route of Administration","longName":"2577989","preferredDefinition":"Administration to or in the interstices of a tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interstitial Route of Administration","conceptCode":"C38219","definition":"Drug administration to or in the interstices of a tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F5D-4ACD-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown Route of Administration","ValueMeaning":{"publicId":"2577944","version":"1","preferredName":"Unknown Route of Administration","longName":"2577944v1.00","preferredDefinition":"The route of drug administration is unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown Route of Administration","conceptCode":"C38311","definition":"The route of drug administration is unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD85-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"CLOHNES","dateModified":"2023-07-11","changeDescription":null,"administrativeNotes":"7/11/23 Edited so definition of VM is visible per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F67-4ACD-E044-0003BA3F9857","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"ID","valueDescription":"Intradermal","ValueMeaning":{"publicId":"2562291","version":"1","preferredName":"Intradermal","longName":"2562291","preferredDefinition":"Within the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intradermal","conceptCode":"C28213","definition":"Within the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C060-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"ZHANGWE","dateModified":"2021-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F71-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IV","valueDescription":"Intravenous Bolus","ValueMeaning":{"publicId":"2581084","version":"1","preferredName":"Intravenous Bolus","longName":"2581084","preferredDefinition":"Administration of a drug directly into circulation via a vein or veins over a time duration of less than or equal to 30 minutes. Method results in 100% bioavailability of the agent due to an absence of the absorption phase. FDA CDER (HL7) numeric code: 0138","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Bolus","conceptCode":"C38274","definition":"A volume of drug intended to be administered into a vein at a relatively fast rate. The volume of drug and the rate of administration are specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09C9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F7B-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IVI","valueDescription":"Intravenous Infusion","ValueMeaning":{"publicId":"2562292","version":"1","preferredName":"Intravenous Infusion","longName":"2562292","preferredDefinition":"Introduction of a drug directly into venous circulation over the time duration of more than 30 minutes but less than 24 hours. Method results in 100% bioavailability of the agent due to an absence of the absorption phase and provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index. To achieve the steady state quickly, the loading dose is used. Intravenously administered drug is diluted in the pooled venous blood and pumped through lungs before entering systematic circulation (lung first-pass effect). The target organ receives only the fraction of drug corresponding to the fraction of received arterial blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Infusion","conceptCode":"C38275","definition":"Introduction of a drug directly into venous circulation over the time duration of more than 30 minutes but less than 24 hours. Method results in 100% bioavailability of the agent due to an absence of the absorption phase and provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index. To achieve the steady state quickly, the loading dose is used. Intravenously administered drug is diluted in the pooled venous blood and pumped through lungs before entering systematic circulation (lung first-pass effect). The target organ receives only the fraction of drug corresponding to the fraction of received arterial blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C061-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F85-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"CIV","valueDescription":"Continuous Intravenous Infusion","ValueMeaning":{"publicId":"2574001","version":"1","preferredName":"Continuous Intravenous Infusion","longName":"2574001","preferredDefinition":"A route of administration of a fluid drug form into a vein or veins, over a time duration of equal to or more than 24 hours. Method allows to maintain steady state plasma/serum medication levels, a smaller total daily dose of drug to achieve the same pharmacodynamic endpoint in comparison with intermittent or bolus infusion, and may result in lower toxicity. The method has a positive impact on health-care costs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Continuous Intravenous Infusion","conceptCode":"C38196","definition":"A route of administration of a fluid drug form into a vein or veins, over a time duration of equal to or more than 24 hours. Method allows to maintain steady state plasma/serum medication levels, a smaller total daily dose of drug to achieve the same pharmacodynamic endpoint in comparison with intermittent or bolus infusion, and may result in lower toxicity. The method has a positive impact on health-care costs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE1E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"COOPERM","dateModified":"2017-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F8F-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IA","valueDescription":"Intra-Arterial","ValueMeaning":{"publicId":"2562293","version":"1","preferredName":"Intra-Arterial","longName":"2562293","preferredDefinition":"Within an artery (blood vessel that carries blood from the heart to tissues and organs in the body).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intra-arterial","conceptCode":"C94248","definition":"Within an artery (blood vessel that carries blood from the heart to tissues and organs in the body).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C062-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6F99-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"SC","valueDescription":"Subcutaneous","ValueMeaning":{"publicId":"2562294","version":"1","preferredName":"Subcutaneous","longName":"2562294","preferredDefinition":"Beneath the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subcutaneous","conceptCode":"C13353","definition":"Beneath the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C063-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FA3-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IT","valueDescription":"Intrathecal","ValueMeaning":{"publicId":"2574002","version":"1","preferredName":"Intrathecal","longName":"2574002","preferredDefinition":"Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Route of Administration","conceptCode":"C38267","definition":"Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE1F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FAD-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IP","valueDescription":"Intraperitoneal","ValueMeaning":{"publicId":"2574003","version":"1","preferredName":"Intraperitoneal","longName":"2574003","preferredDefinition":"(IN-tra-per-ih-toe-NEE-al) IP.  Within the peritoneal cavity (the area that contains the abdominal organs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraperitoneal","conceptCode":"C13352","definition":"Relating to the peritoneal cavity as the intended site of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE20-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FB7-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IH","valueDescription":"Intrahepatic","ValueMeaning":{"publicId":"2562295","version":"1","preferredName":"Intrahepatic","longName":"2562295","preferredDefinition":"(in-tra-hep-AT-ik) Within the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic","conceptCode":"C13808","definition":"Within the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C064-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FC1-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IHI","valueDescription":"Intrahepatic Infusion","ValueMeaning":{"publicId":"2574006","version":"1","preferredName":"Intrahepatic Infusion","longName":"2574006","preferredDefinition":"Administration of a fluid form of the drug via a blood vessel into the liver over the sustained period of time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic Infusion Procedure","conceptCode":"C15731","definition":"Administration of a fluid form of the drug via a blood vessel into the liver over the sustained period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE23-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FCB-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"PO","valueDescription":"Oral","ValueMeaning":{"publicId":"2562296","version":"1","preferredName":"Oral","longName":"2562296","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FD5-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"RT","valueDescription":"Radiation","ValueMeaning":{"publicId":"2574107","version":"1","preferredName":"Radiation","longName":"2574107","preferredDefinition":"The area of the body exposed to radiation during radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Field","conceptCode":"C54648","definition":"The area of the body exposed to radiation during radiation therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE88-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FDF-4ACD-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"PR","valueDescription":"Rectal","ValueMeaning":{"publicId":"2565646","version":"1","preferredName":"Rectal","longName":"2565646","preferredDefinition":"Related to the rectum","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal","conceptCode":"C25224","definition":"Of or pertaining to the rectum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CD7B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-24","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-24","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FE9-4ACD-E044-0003BA3F9857","beginDate":"2003-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Transdermal","valueDescription":"Transdermal","ValueMeaning":{"publicId":"2567784","version":"1","preferredName":"Transdermal","longName":"2567784","preferredDefinition":"Through the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transdermal","conceptCode":"C28017","definition":"Referring to the application of medication through the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FF3-4ACD-E044-0003BA3F9857","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Sublingual","valueDescription":"Sublingual","ValueMeaning":{"publicId":"2567884","version":"1","preferredName":"Sublingual","longName":"2567884","preferredDefinition":"Beneath the tongue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sublingual","conceptCode":"C89785","definition":"Beneath the tongue.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D639-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-6FFD-4ACD-E044-0003BA3F9857","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"IM","valueDescription":"Intramuscular","ValueMeaning":{"publicId":"2562290","version":"1","preferredName":"Intramuscular","longName":"2562290","preferredDefinition":"Intramuscular.  Within or into muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramuscular","conceptCode":"C27974","definition":"Within or into muscle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C05F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7007-4ACD-E044-0003BA3F9857","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"NASAL","valueDescription":"Nasal","ValueMeaning":{"publicId":"2568340","version":"1","preferredName":"Nasal","longName":"2568340","preferredDefinition":"Administration to the nose; administered by way of the nose.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal","conceptCode":"C27958","definition":"In reference to the nose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D801-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7011-4ACD-E044-0003BA3F9857","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"SWSP","valueDescription":"Swish & Spit","ValueMeaning":{"publicId":"2568341","version":"1","preferredName":"Swish & Spit","longName":"2568341","preferredDefinition":"Administration of a liquid substance to the oral mucosa by swishing the drug inside the mouth for a certain amount of time then spiting it out. The drug action is mostly topical/local.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Swish and Spit Route of Administration","conceptCode":"C38302","definition":"Administration of a liquid substance to the oral mucosa by swishing the drug inside the mouth for a certain amount of time then spiting it out. The drug action is mostly topical/local.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D802-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-02","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-701B-4ACD-E044-0003BA3F9857","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"SWSW","valueDescription":"Swish & Swallow","ValueMeaning":{"publicId":"2568342","version":"1","preferredName":"Swish & Swallow","longName":"2568342","preferredDefinition":"Administration of a liquid substance to the oral mucosa by swishing the drug inside the mouth for a certain amount of time then allowed to be swallowed. The drug action is both topical and systemic","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Swish and Swallow Route of Administration","conceptCode":"C38303","definition":"Administration of a liquid substance to the oral mucosa by swishing the drug inside the mouth for a certain amount of time then allowed to be swallowed. The drug action is both topical and systemic","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D803-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-02","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7025-4ACD-E044-0003BA3F9857","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"TOP","valueDescription":"Topical","ValueMeaning":{"publicId":"2574005","version":"1","preferredName":"Topical","longName":"2574005","preferredDefinition":"On the surface of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Topical","conceptCode":"C13344","definition":"On the surface of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE22-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-702F-4ACD-E044-0003BA3F9857","beginDate":"2004-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"NG","valueDescription":"Nasogastric","ValueMeaning":{"publicId":"2568390","version":"1","preferredName":"Nasogastric","longName":"2568390","preferredDefinition":"Administration through the nose and into the stomach, usually by means of a tube.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasogastric Route of Administration","conceptCode":"C38285","definition":"Administration of a drug through the nose and into the stomach, usually by means of a tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D833-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7039-4ACD-E044-0003BA3F9857","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Inhalatn","valueDescription":"Inhalation","ValueMeaning":{"publicId":"2568389","version":"1","preferredName":"Inhalation","longName":"2568389","preferredDefinition":"Access within the respiratory tract by inhaling orally or nasally for a systemic or local effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspiration, CTCAE","conceptCode":"C28245","definition":"A disorder characterized by inhalation of solids or liquids into the lungs.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D832-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7043-4ACD-E044-0003BA3F9857","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"G Tube","valueDescription":"Gastrostomy Tube","ValueMeaning":{"publicId":"2569955","version":"1","preferredName":"Gastrostomy Tube","longName":"2569955","preferredDefinition":"Drug administration through a gastric fistula or a surgically created artificial opening into the stomach through the abdominal wall with insertion of a tube.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration via Gastrostomy","conceptCode":"C38199","definition":"Drug administration through a gastric fistula or a surgically created artificial opening into the stomach through the abdominal wall with insertion of a tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DE50-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-07","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-704D-4ACD-E044-0003BA3F9857","beginDate":"2004-06-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Oph Each","valueDescription":"Ophthalmic, Each Eye","ValueMeaning":{"publicId":"2568388","version":"1","preferredName":"Ophthalmic, Each Eye","longName":"2568388","preferredDefinition":"Used to refer to every member of a group of people or things, considered individually.: The organ of sight or vision.: Administration of a drug to the external eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Each","conceptCode":"C64933","definition":"Used to refer to every member of a group of people or things, considered individually.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Eye","conceptCode":"C12401","definition":"The organ of sight or vision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ophthalmic Route of Administration","conceptCode":"C38287","definition":"Administration of a drug to the external surfaces of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D831-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7057-4ACD-E044-0003BA3F9857","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Oph Left","valueDescription":"Ophthalmic, Left Eye","ValueMeaning":{"publicId":"2568386","version":"1","preferredName":"Ophthalmic, Left Eye","longName":"2568386","preferredDefinition":"Being or located on or directed toward the side of the body to the west when facing north.: The organ of sight or vision.: Administration of a drug to the external eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Left","conceptCode":"C25229","definition":"Being or located on or directed toward the side of the body to the west when facing north.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Eye","conceptCode":"C12401","definition":"The organ of sight or vision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ophthalmic Route of Administration","conceptCode":"C38287","definition":"Administration of a drug to the external surfaces of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D82F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7061-4ACD-E044-0003BA3F9857","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Oph Rt","valueDescription":"Ophthalmic, Right Eye","ValueMeaning":{"publicId":"2568387","version":"1","preferredName":"Ophthalmic, Right Eye","longName":"2568387","preferredDefinition":"Right; being or located on or directed toward the side of the body to the east when facing north.: The organ of sight or vision.: Administration of a drug to the external eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Right","conceptCode":"C25228","definition":"Being or located on or directed toward the side of the body to the east when facing north.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Eye","conceptCode":"C12401","definition":"The organ of sight or vision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ophthalmic Route of Administration","conceptCode":"C38287","definition":"Administration of a drug to the external surfaces of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D830-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-706B-4ACD-E044-0003BA3F9857","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"INTUM","valueDescription":"Intratumoral","ValueMeaning":{"publicId":"2572873","version":"1","preferredName":"Intratumoral","longName":"2572873","preferredDefinition":"Within a tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral","conceptCode":"C28036","definition":"Within a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9B6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-16","modifiedBy":"COOPERM","dateModified":"2017-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-7075-4ACD-E044-0003BA3F9857","beginDate":"2005-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Vaginal","valueDescription":"Vaginal Route","ValueMeaning":{"publicId":"2575266","version":"1","preferredName":"Vaginal Route","longName":"2575266","preferredDefinition":"Relating to the vagina or to any sheath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal","conceptCode":"C13309","definition":"Of or relating to the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F30F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-02","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C2E-707F-4ACD-E044-0003BA3F9857","beginDate":"2005-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Transmucosal","valueDescription":"Transmucosal Route","ValueMeaning":{"publicId":"2635256","version":"1","preferredName":"Transmucosal Route","longName":"2635256","preferredDefinition":"Administration of a substance to the mucosa; often resulting in systemic action due to absorption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucosal Route of Administration","conceptCode":"C38283","definition":"Administration of a substance to the mucosa; often resulting in systemic action due to absorption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6E8C91-335A-4FD7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F6E8C91-3374-4FD7-E044-0003BA3F9857","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"REEVESD","dateModified":"2007-05-01","deletedIndicator":"No"},{"value":"Intraventricular","valueDescription":"Intraventricular Route of Administration","ValueMeaning":{"publicId":"2578016","version":"1","preferredName":"Intraventricular Route of Administration","longName":"2578016","preferredDefinition":"Administration within a ventricle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraventricular Route of Administration","conceptCode":"C38277","definition":"Administration of a drug directly into a cerebral ventricle, commonly using a reservoir. This allows a more even distribution of drug through the cerebrospinal fluid (CSF) and is particularly useful in the treatment of certain types of cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDCD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3615C085-00FB-7412-E044-0003BA3F9857","beginDate":"2007-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-07-25","modifiedBy":"REEVESD","dateModified":"2007-07-25","deletedIndicator":"No"},{"value":"Intravesical","valueDescription":"Intravesical","ValueMeaning":{"publicId":"3124962","version":"1","preferredName":"Intravesical","longName":"3124962","preferredDefinition":"Within the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravesical","conceptCode":"C13415","definition":"Within the bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C858C96-4E7D-24BB-E040-BB89AD430653","latestVersionIndicator":"Yes","beginDate":"2010-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8C858C96-4E96-24BB-E040-BB89AD430653","beginDate":"2010-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-29","modifiedBy":"ONEDATA","dateModified":"2010-07-29","deletedIndicator":"No"},{"value":"Oral and IV","valueDescription":"Oral and Intravenous Route of Administration","ValueMeaning":{"publicId":"3689253","version":"1","preferredName":"Oral and Intravenous Route of Administration","longName":"3689253","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Administration within or into a vein or veins.: The course by which a substance was administered in order to reach the site of action in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D62B8718-8D55-F9C9-E040-BB89AD430D9F","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D62B8718-8D6E-F9C9-E040-BB89AD430D9F","beginDate":"2013-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-20","modifiedBy":"ONEDATA","dateModified":"2013-02-20","deletedIndicator":"No"},{"value":"Urethral","valueDescription":"Intraurethral Route of Administration","ValueMeaning":{"publicId":"2577935","version":"1","preferredName":"Intraurethral Route of Administration","longName":"2577935","preferredDefinition":"Administration of a drug directly into the urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraurethral Route of Administration","conceptCode":"C38271","definition":"Administration of a drug directly into the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4AC7A36-A4F6-8ABD-E040-BB89AD436139","beginDate":"2013-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-01","modifiedBy":"ONEDATA","dateModified":"2013-02-01","deletedIndicator":"No"},{"value":"Intrauterine","valueDescription":"Intrauterine Route of Administration","ValueMeaning":{"publicId":"2577981","version":"1","preferredName":"Intrauterine Route of Administration","longName":"2577981","preferredDefinition":"Administration within the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrauterine Route of Administration","conceptCode":"C38272","definition":"The administration of a drug within the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4AC7A36-A50A-8ABD-E040-BB89AD436139","beginDate":"2013-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-01","modifiedBy":"ONEDATA","dateModified":"2013-02-01","deletedIndicator":"No"},{"value":"IC","valueDescription":"Corpora Cavernosa Intracavernous Route of Administration","ValueMeaning":{"publicId":"5676172","version":"1","preferredName":"Corpora Cavernosa Intracavernous Route of Administration","longName":"5676172","preferredDefinition":"One of two chambers along the shaft of the penis containing spongy erectile tissue, which, combined with the Corpus Spongiosum, fill with blood to create a penile erection.: Administration of a drug within a pathologic cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corpora Cavernosa","conceptCode":"C32382","definition":"One of two chambers along the shaft of the penis containing spongy erectile tissue, which, combined with the Corpus Spongiosum, fill with blood to create a penile erection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intracavernous Route of Administration","conceptCode":"C38230","definition":"Administration of a drug within a pathologic cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49238841-39F1-45C4-E053-F662850A070C","latestVersionIndicator":"Yes","beginDate":"2017-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"49238841-3A0A-45C4-E053-F662850A070C","beginDate":"2017-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-22","modifiedBy":"ONEDATA","dateModified":"2017-02-22","deletedIndicator":"No"},{"value":"I-CAVERN","valueDescription":null,"ValueMeaning":{"publicId":"2577933","version":"1","preferredName":"Intracavernous Route of Administration","longName":"2577933","preferredDefinition":"Administration of a drug within a pathologic cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracavernous Route of Administration","conceptCode":"C38230","definition":"Administration of a drug within a pathologic cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E10A6ABC-4D1C-2FAE-E053-731AD00A4F5C","beginDate":"2022-06-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-14","modifiedBy":"GDEEN","dateModified":"2022-06-14","deletedIndicator":"No"},{"value":"I-ARTIC","valueDescription":null,"ValueMeaning":{"publicId":"2577992","version":"1","preferredName":"Intraarticular Route of Administration","longName":"2577992","preferredDefinition":"Administration within a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarticular Route of Administration","conceptCode":"C38223","definition":"Administration of the drug within a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E10A6ABC-4D7D-2FAE-E053-731AD00A4F5C","beginDate":"2022-06-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-14","modifiedBy":"GDEEN","dateModified":"2022-06-14","deletedIndicator":"No"},{"value":"INJ","valueDescription":null,"ValueMeaning":{"publicId":"6072644","version":"1","preferredName":"Injection","longName":"6072644","preferredDefinition":"Use of a syringe and needle to push fluids or drugs into the body; often called a \"shot.\"","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Route of Administration","conceptCode":"C28160","definition":"Administration of a drug into a location within the body; this can be achieved either through an established access or via a needle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"654690B1-71BC-7B37-E053-F662850A641B","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-15","modifiedBy":"SOKKERL","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"02851AD3-D913-6BC9-E063-731AD00A29AD","beginDate":"2023-08-09","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-08-09","modifiedBy":"MMADDINENI","dateModified":"2023-08-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2635255","version":"1","preferredName":"Route of Administration Text Code","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.:Text; the words of something written.:A system of numbered categories for representation of data.","longName":"C38114:C25704:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6E8C2E-6F20-4ACD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6E8C2E-6F31-4ACD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"MMADDINENI","dateModified":"2023-08-10","changeDescription":"v6.0 uses lengthened maximum field length.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811686","version":"1","longName":"CTMSv3.02","context":"CCR"},{"publicId":"3248646","version":"1","longName":"Study Med Administration","context":"CCR"},{"publicId":"3248617","version":"1","longName":"CCR 2011 Template","context":"CCR"},{"publicId":"3248622","version":"1","longName":"Concomitant Meds/Measures","context":"CCR"}]},{"publicId":"2180933","version":"1","longName":"FNL Research Activities","context":"CIP","ClassificationSchemeItems":[{"publicId":"2812330","version":"1","longName":"Series","context":"CIP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"},{"publicId":"2812586","version":"1","longName":"Lombardi 04251","context":"NCIP"},{"publicId":"2812585","version":"1","longName":"Lombardi 03058","context":"NCIP"},{"publicId":"2812727","version":"1","longName":"U of Pa Cancer Center","context":"NCIP"},{"publicId":"2812574","version":"1","longName":"UPCC 07403","context":"NCIP"},{"publicId":"2812726","version":"1","longName":"U Nebraska Med Center","context":"NCIP"},{"publicId":"2812981","version":"1","longName":"UNMC 284-04","context":"NCIP"},{"publicId":"2811716","version":"1","longName":"UC Irvine","context":"NCIP"},{"publicId":"2812578","version":"1","longName":"UCI 0404","context":"NCIP"},{"publicId":"2812577","version":"1","longName":"DFMO/Sul Colon III UCI 02_06","context":"NCIP"},{"publicId":"2812584","version":"1","longName":"Lombardi 02452","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812573","version":"1","longName":"Albert Einstein Medical Center","context":"NCIP"},{"publicId":"2812812","version":"1","longName":"AE_104_085","context":"NCIP"},{"publicId":"2812583","version":"1","longName":"Panvec","context":"NCIP"},{"publicId":"2812693","version":"1","longName":"Northwestern University","context":"NCIP"},{"publicId":"2812695","version":"1","longName":"NU 0943_011","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812581","version":"1","longName":"DC_0205","context":"NCIP"},{"publicId":"2812582","version":"1","longName":"P1_CPT_BCNU_RD","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"},{"publicId":"2812733","version":"1","longName":"FMISO Study","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3449457","version":"1","longName":"Study Agent Administration","context":"NCIP"},{"publicId":"2867242","version":"1","longName":"Concomitant Medication CRF","context":"NCIP"},{"publicId":"2867243","version":"1","longName":"Prior/Post Therapies CRF","context":"NCIP"},{"publicId":"2812342","version":"1","longName":"Proposed","context":"NCIP"},{"publicId":"2812976","version":"1","longName":"LOINC Lab Tests","context":"NCIP"}]},{"publicId":"2614828","version":"1","longName":"NCIA Collection","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812770","version":"1","longName":"LIDC","context":"NCIP"},{"publicId":"2812803","version":"1","longName":"Case-Study-Series","context":"NCIP"},{"publicId":"2812806","version":"1","longName":"Series","context":"NCIP"}]},{"publicId":"2716207","version":"1","longName":"ASCO (American Society of Clinical Oncology)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2861473","version":"1","longName":"Chemotherapy Administration","context":"NCIP"},{"publicId":"2812713","version":"1","longName":"Breast Cancer Adjuvant Treatment","context":"NCIP"},{"publicId":"2812709","version":"1","longName":"Colon Adjuvant Treatment Summary","context":"NCIP"},{"publicId":"2898482","version":"1","longName":"Lung Cancer","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"2857175","version":"1","longName":"C3D Adopter CDEs for Reuse","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812490","version":"1","longName":"CTMS 3.12B","context":"CCR"}]},{"publicId":"2931931","version":"1","longName":"Iloprost Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2931952","version":"1","longName":"Iloprost 12079","context":"SPOREs"}]},{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]},{"publicId":"3194026","version":"1","longName":"KAI Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3211763","version":"1","longName":"Study Drug/Intervention Administration","context":"NCIP"},{"publicId":"2812550","version":"1","longName":"General CDEs","context":"NCIP"},{"publicId":"10000286","version":"1","longName":"Prior and Concomitant Medications","context":"NCIP"}]},{"publicId":"3234177","version":"1","longName":"Patient Outcomes Data System (PODS)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3234178","version":"1","longName":"PODS Elements","context":"NCIP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461588","version":"1","longName":"General Elements","context":"NCIP"},{"publicId":"3461589","version":"1","longName":"Imaging Elements","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"},{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787504","version":"1","longName":"GBM","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787510","version":"1","longName":"LGG","context":"NCIP"},{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"}]},{"publicId":"3886753","version":"1","longName":"General Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902138","version":"1","longName":"General","context":"BOLD"}]},{"publicId":"3886754","version":"1","longName":"Imaging Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902139","version":"1","longName":"Imaging","context":"BOLD"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528052","version":"1","longName":"MAY2013-02-01","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"},{"publicId":"5981652","version":"1","longName":"UAZ2017-09-02","context":"DCP"},{"publicId":"6046252","version":"1","longName":"UAZ2016-08-02","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104901","version":"1","longName":"GOG-0286B","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635322","version":"1","longName":"Prior/Post Therapies","context":"NCI Standards"},{"publicId":"10000582","version":"1","longName":"Study Agent Administration","context":"NCI Standards"},{"publicId":"5635301","version":"1","longName":"Concomitant Medication","context":"NCI Standards"}]}],"AlternateNames":[{"name":"RTE_NM","type":"C3D Name","context":"CCR"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"},{"name":"SPOREs","type":"USED_BY","context":"SPOREs"},{"name":"ACCESS_RTE_TXT_CD","type":"USED_BY","context":"NCIP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"Route Of Administration","type":"TCGA_Name","context":"NCIP"},{"name":"route_of_administration","type":"TCGA_XML_Name","context":"NCIP"},{"name":"ACCESS_RTE_TXT_CD","type":"USED_BY","context":"CITN"},{"name":"BOLD","type":"USED_BY","context":"BOLD"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"ACCESS_RTE_TXT_CD","type":"USED_BY","context":"NRG"},{"name":"ACCESS_RTE_TXT_CD","type":"USED_BY","context":"OHSU Knight"},{"name":"ACCESS_RTE_TXT_CD","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Route","type":"Preferred Question Text","description":"Route","url":null,"context":"CCR"},{"name":"CRF TEXT1","type":"Alternate Question Text","description":"Route Name","url":null,"context":"NCIP"},{"name":"Chemotherapy drug route","type":"Alternate Question Text","description":"Chemotherapy drug route","url":null,"context":"CCR"},{"name":"Chemotherapy Route of Administration","type":"Alternate Question Text","description":"Chemotherapy Route of Administration","url":null,"context":"NCIP"},{"name":"Route of Administration","type":"Alternate Question Text","description":"Route of Administration","url":null,"context":"NCIP"},{"name":"Planned Route","type":"Alternate Question Text","description":"Planned Route","url":null,"context":"CCR"},{"name":"Dosage Form","type":"Alternate Question Text","description":"Dosage Form","url":null,"context":"NCIP"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"Type of injection","url":null,"context":"DCP"},{"name":"DCP Question","type":"Alternate Question Text","description":"Route","url":null,"context":"DCP"},{"name":"DCP-Text-2","type":"Alternate Question Text","description":"Agent Administration:Route","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"2F6EA110-B303-52A4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Replaces v5.0 w/extended max field length. Permissible value of 'oral' (po) and alternate question text requested per 3/10/2010 request of G. Diaz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}